57968-81-7 Usage
Description
(+)-5-trans Cloprostenol is an isomer of cloprostenol (C587300), which is an aryl-oxymethyl analog of prostaglandin F2α. It is a chemical compound with specific properties that make it useful in various applications across different industries.
Uses
Used in Pharmaceutical Industry:
(+)-5-trans Cloprostenol is used as a pharmaceutical agent for its prostaglandin-like properties. It is particularly effective in treating various medical conditions due to its ability to mimic the actions of prostaglandin F2α, which plays a crucial role in various physiological processes.
Used in Veterinary Medicine:
In the veterinary medicine industry, (+)-5-trans Cloprostenol is used as a veterinary drug for managing reproductive issues in animals. Its prostaglandin-like properties make it an effective treatment for conditions such as estrus synchronization, abortion, and the treatment of certain reproductive disorders.
Used in Research and Development:
(+)-5-trans Cloprostenol is also utilized in research and development for studying the effects of prostaglandins on various biological systems. Its unique properties allow scientists to investigate the mechanisms of action and potential therapeutic applications of prostaglandin F2α and its analogs.
Check Digit Verification of cas no
The CAS Registry Mumber 57968-81-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,9,6 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 57968-81:
(7*5)+(6*7)+(5*9)+(4*6)+(3*8)+(2*8)+(1*1)=187
187 % 10 = 7
So 57968-81-7 is a valid CAS Registry Number.
57968-81-7Relevant articles and documents
Synthesis of (±) travoprost and its analogs
Mudduluru, Harikrishna,Hindupur, Rama M.,Dubey, Pramod K.,Madhavaram, Shankar,Tatini, Lakshmikumar,Subbaraju, Gottumukkala V.
experimental part, p. 234 - 241 (2012/04/18)
A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner-Wadsworth-Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
